{
    "nct_id": "NCT06080061",
    "official_title": "Phase I Trial of Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer",
    "inclusion_criteria": "* Histologically or cytologically documented malignancy of the lung including non-small cell lung cancer or small cell lung cancer planned for definitive therapy with fractionated radiation (60-66 Gy) and concurrent systemic therapy\n* ECOG performance status of 0-2\n* Age > 18 years old\n* Ability to understand and the willingness to personally sign the written IRB approved informed consent document\n* Estimated life expectancy of 12 weeks or longer\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Contraindication to receiving radiotherapy or systemic therapy as determined by treating radiation and medical oncologist\n* Age < 18 years old\n* Tumor directly invading the major pulmonary arteries, aorta, heart or proximal bronchial tree\n* Diagnosis of interstitial pulmonary fibrosis\n* Previous radiation therapy to the thorax that would result in overlapping high dose radiation fields",
    "miscellaneous_criteria": ""
}